Fantastic news today as children with leukaemia will be able to access CAR-T therapy on the NHS. The CAR-T cells in this pilot have been derived from peripheral blood. Groups are working on the same process using CAR-T cells from umbilical cord blood, a non-invasive source of therapeutic cells. Biovault’s Shaun Mansfield, a stem cell scientist specialising in umbilical cord cells says: “We’re delighted at this step forward in cell-based therapies.”
Children with leukaemia to receive CAR-T therapy on the NHS
Naturally, we hope no family will ever need to use their child's stem cells. But sometimes they do. That's why we make sure every collection in our care is treated with exceptional attention to detail. We want to give families the best possible chance of a healthy future.
Let's get you started
Cord blood processing and storage for families. Choose a 25 year storage period, annual storage and reduced fees for twins.
Cord blood and tissue storage for families wishing to store stem cell-rich umbilical tissue as well as cord blood.